Influence of ω-3 polyunsaturated fatty acids on the structure of immunocompetent cell membranes and the parameters of cellular and humoral immunity in children with rheumatoid arthritis

• Authors: Yarema Natalia , Fedortsiv Olga , Palasiuk Bohdan
• Languages of publication: EN

Keywords

EN

rheumatoid arthritis (RA); fatty acids; immune system; cel membrane; child.

• Publisher: Stowarzyszenie Przyjaciół Medycyny Rodzinnej i Lekarzy Rodzinnych
• Journal: Family Medicine & Primary Care Review
• Year: 2018
• Issue: 1
• Pages: 78-82

Contributors

author

Yarema Natalia

author

Fedortsiv Olga

author

Palasiuk Bohdan

References

• Langford RM. Pain management today – what have we learned? Clin Rheumatol 2006; 25(Suppl. 1): S2–S8.
• Chen M, Lam BK, Kanaoka Y, et al. Neutrophil-derived leukotriene B4 is required for inflammatory arthritis. J Exp Med 2006; 203(4):837–842.
• Cleland LG, James MJ, Proudman SM. Fish oil: what the prescriber needs to know. Arthritis Res Ther 2006; 8(1): 202.
• Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006; 83(6 Suppl.): 1505S–1519S.
• Goldberg RJ, Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain 2007; 129(1–2): 210–223.
• World Health Organisation. Population nutrient intake goals for preventing diet-related chronic diseases [cited 06.11.2014]. Available from URL: http://www.who.int/nutrition/topics/5_population_nutrient/en/index13.html.
• Barros R, Moreira A, Fonseca J, et al. Dietary intake of alpha-linolenic acid and low ratio of n-6:n-3 PUFA are associated with decreased exhaled NO and improved asthma control. Br J Nutr 2011; 106(3): 441–450.
• Fransen J, van Riel PL. The disease activity score and the EULAR response criteria. Clin Exp Rheumatol 2005; 23(5 Suppl. 39): S93–S99.
• Mancini G, Carbonara AO, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965; 2(3): 235–254.
• Yarema NM. ω-3 polyunsaturated fatty acids use for optimization of children inflammatory joints diseases treatment. Voprosy pitaniia 2017; 2: 84–90.
• Casula M, Soranna D, Catapano AL, et al. Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: a meta-analysis of randomized, placebo controlled trials [corrected]. Atheroscler Suppl 2013; 14(2):243–251.
• Galarraga B, Ho M, Youssef HM, et al. Cod liver oil (n-3 fatty acids) as a non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis. Rheumatology (Oxford) 2008; 47(5): 665–669.
• Lee YH, Bae SC, Song GG. Omega-3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-analysis. Arch Med Res 2012; 43(5): 356–362.
• VanderBorght A, Geusens P, Raus J, et al. The autoimmune pathogenesis of rheumatoid arthritis: role of autoreactive T cells and new immunotherapies. Semin Arthritis Rheum 2001; 31(3): 160–175.
• McCann ME, Moore JN, Carrick JB et al. Effect of intravenous infusion of omega-3 and omega-6 lipid emulsions on equine monocyte fatty acid composition and inflammatory mediator production in vitro. Shock 2000; 14(2): 222–228.
• Hou TY, McMurray DN, Chapkin RS. Omega-3 fatty acids, lipid rafts, and T cell signaling. Eur J Pharmacol 2016; 785: 2–9, doi: 10.1016/j.ejphar.2015.03.091.